Robert Cascella - Net Worth and Insider Trading
Robert Cascella Net Worth
The estimated net worth of Robert Cascella is at least $30 Million dollars as of 2024-12-26. Robert Cascella is the CEO and President of Hologic Inc and owns about 401,438 shares of Hologic Inc (HOLX) stock worth over $29 Million. Robert Cascella is the Director of Neuronetics Inc and owns about 453,098 shares of Neuronetics Inc (STIM) stock worth over $661,523. Robert Cascella is also the Director of KORU Medical Systems Inc and owns about 41,478 shares of KORU Medical Systems Inc (KRMD) stock worth over $166,119. Details can be seen in Robert Cascella's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Cascella has not made any transactions after 2024-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Cascella
Robert Cascella Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Cascella owns 4 companies in total, including Hologic Inc (HOLX) , KORU Medical Systems Inc (KRMD) , and Neuronetics Inc (STIM) among others .
Click here to see the complete history of Robert Cascella’s form 4 insider trades.
Insider Ownership Summary of Robert Cascella
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HOLX | Hologic Inc | 2013-07-01 | Chief Operating Officer |
| KRMD | KORU Medical Systems Inc | 2023-08-16 | director |
| STIM | Neuronetics Inc | 2024-09-12 | director |
 | | 2021-10-20 | director |
Robert Cascella Latest Holdings Summary
Robert Cascella currently owns a total of 3 stocks. Among these stocks, Robert Cascella owns 401,438 shares of Hologic Inc (HOLX) as of July 1, 2013, with a value of $29 Million and a weighting of 97.24%. Robert Cascella owns 453,098 shares of Neuronetics Inc (STIM) as of September 12, 2024, with a value of $661,523 and a weighting of 2.2%. Robert Cascella also owns 41,478 shares of KORU Medical Systems Inc (KRMD) as of August 16, 2023, with a value of $166,119 and a weighting of 0.55%.
Latest Holdings of Robert Cascella
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HOLX | Hologic Inc | 2013-07-01 | 401,438 | 72.68 | 29,176,514 |
| STIM | Neuronetics Inc | 2024-09-12 | 453,098 | 1.46 | 661,523 |
| KRMD | KORU Medical Systems Inc | 2023-08-16 | 41,478 | 4.01 | 166,119 |
Holding Weightings of Robert Cascella
Robert Cascella Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Cascella has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the sale of 20,000 shares on July 1, 2013, which brought Robert Cascella around $391,000.
According to the SEC Form 4 filings, Robert Cascella has made a total of 7 transactions in Neuronetics Inc (STIM) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Neuronetics Inc is the acquisition of 100,000 shares on September 12, 2024, which cost Robert Cascella around $75,000.
According to the SEC Form 4 filings, Robert Cascella has made a total of 1 transactions in KORU Medical Systems Inc (KRMD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in KORU Medical Systems Inc is the acquisition of 19,000 shares on August 16, 2023, which cost Robert Cascella around $49,590.
Insider Trading History of Robert Cascella
- 1
Robert Cascella Trading Performance
GuruFocus tracks the stock performance after each of Robert Cascella's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Cascella is -23.12%. GuruFocus also compares Robert Cascella's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Cascella within 3 months outperforms 1 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Cascella's insider trading performs compared to the benchmark.
Performance of Robert Cascella
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.66 | | | | | |
| Relative Return to S&P 500(%) | -3.28 | | | | | |
Robert Cascella Ownership Network
Robert Cascella Owned Company Details
What does Hologic Inc do?
Who are the key executives at Hologic Inc?
Robert Cascella is the Chief Operating Officer of Hologic Inc. Other key executives at Hologic Inc include Div. President & GYN Surgical Essex D Mitchell , Corp. VP & Finance & Acconting Karleen Marie Oberton , and Principal Accounting Officer Benjamin Jordan Cohn .
Hologic Inc (HOLX) Insider Trades Summary
Over the past 18 months, Robert Cascella made no insider transaction in Hologic Inc (HOLX). Other recent insider transactions involving Hologic Inc (HOLX) include a net sale of 95,422 shares made by Stephen P Macmillan , a net sale of 67,619 shares made by Karleen Marie Oberton , and a net sale of 32,356 shares made by Essex D Mitchell .
In summary, during the past 3 months, insiders sold 24,856 shares of Hologic Inc (HOLX) in total and bought 0 shares, with a net sale of 24,856 shares. During the past 18 months, 262,967 shares of Hologic Inc (HOLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 262,967 shares.
Hologic Inc (HOLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hologic Inc Insider Transactions
Robert Cascella Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Cascella. You might contact Robert Cascella via mailing address: C/o Hologic, Inc., Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
